Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced...
Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
About this item
Full title
Author / Creator
Publisher
England: Springer
Journal title
Language
English
Formats
Publication information
Publisher
England: Springer
Subjects
More information
Scope and Contents
Contents
Human papillomavirus-associated oropharyngeal cancer (HPV-OSCC) is rapidly increasing in incidence and has unique epidemiologic, molecular, and biologic characteristics. Standard combined modality therapies for head and neck cancer confer a significant risk of morbidity. However, patients with HPV-OSCC are diagnosed at a younger age and have a supe...
Alternative Titles
Full title
Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV+ “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6460733
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6460733
Other Identifiers
ISSN
2059-7347
E-ISSN
2059-7347
DOI
10.1186/s41199-019-0040-5
